Great news...adds further credibility to the science. From the blog just posted!!
"The third crucial element we will demonstrate with this trial involves the ability to actually deliver the therapy to such a large patient population. In addition to Emory University, patients will be treated at the University of Michigan; and most likely Massachusetts General Hospital will be added as a third site (we are still in discussions, but both of us agree that it is likely to happen). "